BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 18429927)

  • 1. Endosomal phosphoinositides and human diseases.
    Nicot AS; Laporte J
    Traffic; 2008 Aug; 9(8):1240-9. PubMed ID: 18429927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myotubularin phosphatases: policing 3-phosphoinositides.
    Robinson FL; Dixon JE
    Trends Cell Biol; 2006 Aug; 16(8):403-12. PubMed ID: 16828287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Consequences of SAC3/FIG4 Phosphatase Deficiency to Phosphoinositides in Patients with Charcot-Marie-Tooth Disease Type-4J.
    Shisheva A; Sbrissa D; Hu B; Li J
    Mol Neurobiol; 2019 Dec; 56(12):8656-8667. PubMed ID: 31313076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotubularin phosphoinositide phosphatases in human diseases.
    Amoasii L; Hnia K; Laporte J
    Curr Top Microbiol Immunol; 2012; 362():209-33. PubMed ID: 23086420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol-3,5-bisphosphate: metabolism and physiological functions.
    Takasuga S; Sasaki T
    J Biochem; 2013 Sep; 154(3):211-8. PubMed ID: 23857703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic interaction between MTMR2 and FIG4 phospholipid phosphatases involved in Charcot-Marie-Tooth neuropathies.
    Vaccari I; Dina G; Tronchère H; Kaufman E; Chicanne G; Cerri F; Wrabetz L; Payrastre B; Quattrini A; Weisman LS; Meisler MH; Bolino A
    PLoS Genet; 2011 Oct; 7(10):e1002319. PubMed ID: 22028665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phosphoinositide conversion mechanism for exit from endosomes.
    Ketel K; Krauss M; Nicot AS; Puchkov D; Wieffer M; Müller R; Subramanian D; Schultz C; Laporte J; Haucke V
    Nature; 2016 Jan; 529(7586):408-12. PubMed ID: 26760201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WANTED - Dead or alive: Myotubularins, a large disease-associated protein family.
    Raess MA; Friant S; Cowling BS; Laporte J
    Adv Biol Regul; 2017 Jan; 63():49-58. PubMed ID: 27666502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease.
    Kim SA; Taylor GS; Torgersen KM; Dixon JE
    J Biol Chem; 2002 Feb; 277(6):4526-31. PubMed ID: 11733541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylinositol Kinases and Phosphatases in
    Nakada-Tsukui K; Watanabe N; Maehama T; Nozaki T
    Front Cell Infect Microbiol; 2019; 9():150. PubMed ID: 31245297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core protein machinery for mammalian phosphatidylinositol 3,5-bisphosphate synthesis and turnover that regulates the progression of endosomal transport. Novel Sac phosphatase joins the ArPIKfyve-PIKfyve complex.
    Sbrissa D; Ikonomov OC; Fu Z; Ijuin T; Gruenberg J; Takenawa T; Shisheva A
    J Biol Chem; 2007 Aug; 282(33):23878-91. PubMed ID: 17556371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy.
    Tosch V; Rohde HM; Tronchère H; Zanoteli E; Monroy N; Kretz C; Dondaine N; Payrastre B; Mandel JL; Laporte J
    Hum Mol Genet; 2006 Nov; 15(21):3098-106. PubMed ID: 17008356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phosphoinositides: lipidic essential actors in the intracellular traffic].
    Bertazzi DL; De Craene JO; Bär S; Sanjuan-Vazquez M; Raess MA; Friant S
    Biol Aujourdhui; 2015; 209(1):97-109. PubMed ID: 26115715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PTEN and Myotubularin phosphoinositide 3-phosphatases: linking lipid signalling to human disease.
    Davies EM; Sheffield DA; Tibarewal P; Fedele CG; Mitchell CA; Leslie NR
    Subcell Biochem; 2012; 58():281-336. PubMed ID: 22403079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CMT4B disease-causing phosphatases Mtmr2 and Mtmr13 localize to the Schwann cell cytoplasm and endomembrane compartments, where they depend upon each other to achieve wild-type levels of protein expression.
    Ng AA; Logan AM; Schmidt EJ; Robinson FL
    Hum Mol Genet; 2013 Apr; 22(8):1493-506. PubMed ID: 23297362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential actions of myotubularin lipid phosphatases regulate endosomal PI(3)P and growth factor receptor trafficking.
    Cao C; Backer JM; Laporte J; Bedrick EJ; Wandinger-Ness A
    Mol Biol Cell; 2008 Aug; 19(8):3334-46. PubMed ID: 18524850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a Charcot-Marie-Tooth 4B2-like peripheral neuropathy in mice.
    Robinson FL; Niesman IR; Beiswenger KK; Dixon JE
    Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4916-21. PubMed ID: 18349142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylinositol-3,5-bisphosphate: no longer the poor PIP2.
    Ho CY; Alghamdi TA; Botelho RJ
    Traffic; 2012 Jan; 13(1):1-8. PubMed ID: 21736686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis, regulation, and roles of endosomal phosphoinositides.
    Maffucci T; Falasca M
    Methods Enzymol; 2014; 535():75-91. PubMed ID: 24377918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of myelin synthesis and actomyosin function underlies aberrant myelin in CMT4B1 neuropathy.
    Guerrero-Valero M; Grandi F; Cipriani S; Alberizzi V; Di Guardo R; Chicanne G; Sawade L; Bianchi F; Del Carro U; De Curtis I; Pareyson D; Parman Y; Schenone A; Haucke V; Payrastre B; Bolino A
    Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33653949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.